Snowball logo
logo
  • Stocks
  • China
  • Healthcare
6880

Sinopep-Allsino Biopharmaceutical Co. Ltd. A

688076 • SHG
¥28.83-¥0.23  (0.79%)
Estimate
P/E
38.4
EPS
0.75
Beta
0.263
Growth
Revenue, YoY
21.55%
Net income, YoY
-45.64%
FCF, YoY
68.4%
Dividends
Dividend yield
1.21%
Annual payout
¥0.35
Next ex. div date
June 12, 27
Payout
149.99%
Div.rating
About the company
Ticker
688076
ISIN
CNE1000051X5
Country
China
Sector (GICS)
Healthcare
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.

Frequently asked questions

What sector does Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) operate in?

Sinopep-Allsino Biopharmaceutical Co. Ltd. A belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) current stock price?

As of the latest data, Sinopep-Allsino Biopharmaceutical Co. Ltd. A stock price is CN¥28.83, with a previous close of CN¥29.06. Sinopep-Allsino Biopharmaceutical Co. Ltd. A lost -CN¥0.23 in the last trading session, representing a -0.79% loss.

What is Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) current market capitalization?

Sinopep-Allsino Biopharmaceutical Co. Ltd. A market cap is approximately 9.13 billion.

What is Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.75.

What is Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) Price-to-Earnings (P/E) ratio?

Sinopep-Allsino Biopharmaceutical Co. Ltd. A current P/E ratio is 38.44.

Does Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) pay dividends?

Yes. Sinopep-Allsino Biopharmaceutical Co. Ltd. A pays annual dividends with an annualized yield of 1.21% and an estimated annual payout of CN¥0.35 per share.

When is the next ex-dividend date for Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076)?

The next ex-dividend date is scheduled for June 12, 2027.

What is Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) beta (volatility) score?

Sinopep-Allsino Biopharmaceutical Co. Ltd. A has a beta of 0.263, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductFor BusinessPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsSnowball Analytics MCPPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.